About
Mighty Therapeutics, through its subsidiary Stealth BioTherapeutics Inc., develops novel therapies targeting mitochondrial dysfunction to treat related diseases.
Explore Mighty Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.